scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1101525895 |
P356 | DOI | 10.1186/S12967-018-1439-1 |
P932 | PMC publication ID | 5851169 |
P698 | PubMed publication ID | 29534721 |
P50 | author | Myron M. Levine | Q29564379 |
Karen L Kotloff | Q63214788 | ||
P2093 | author name string | Franklin R Toapanta | |
Marcelo B Sztein | |||
Paula J Bernal | |||
P2860 | cites work | CD44 binds to the Shigella IpaB protein and participates in bacterial invasion of epithelial cells | Q24290851 |
CD44: from adhesion molecules to signalling regulators | Q28201701 | ||
Shigella-induced apoptosis is dependent on caspase-1 which binds to IpaB | Q28289989 | ||
Early events associated with infection of Epstein-Barr virus infection of primary B-cells | Q28476230 | ||
In situ characterization of inflammatory responses in the rectal mucosae of patients with shigellosis. | Q39833303 | ||
Facile labeling of lipoglycans with quantum dots | Q39894082 | ||
Chemistry and immunochemistry of bacterial lipopolysaccharides as cell wall antigens and endotoxins | Q40105951 | ||
T cell independent antigens | Q40404858 | ||
CD44 isoforms containing exons V6 and V7 are differentially expressed on mitogenically stimulated normal and Epstein-Barr virus-transformed human B cells | Q41304163 | ||
Production of IFN-gamma and IL-10 to Shigella invasins by mononuclear cells from volunteers orally inoculated with a Shiga toxin-deleted Shigella dysenteriae type 1 strain | Q41480678 | ||
Diverse phosphorylation patterns of B cell receptor-associated signaling in naïve and memory human B cells revealed by phosphoflow, a powerful technique to study signaling at the single cell level | Q42421045 | ||
Shigella-induced necrosis and apoptosis of U937 cells and J774 macrophages | Q44569217 | ||
Detection of T-cell degranulation: CD107a and b. | Q45189688 | ||
Studies in volunteers to evaluate candidate Shigella vaccines: further experience with a bivalent Salmonella typhi-Shigella sonnei vaccine and protection conferred by previous Shigella sonnei disease. | Q50464343 | ||
Parenteral immunization with IpaB/IpaD protects mice against lethal pulmonary infection by Shigella. | Q51058305 | ||
Systematic investigation of preparing biocompatible, single, and small ZnS-Capped CdSe quantum dots with amphiphilic polymers. | Q51830005 | ||
Effect of timing of hepatitis B vaccine doses on response to vaccine in Yucpa Indians. | Q52536589 | ||
A modified Shigella volunteer challenge model in which the inoculum is administered with bicarbonate buffer: clinical experience and implications for Shigella infectivity. | Q54158784 | ||
Cloning, expression, and affinity purification of recombinant Shigella flexneri invasion plasmid antigens IpaB and IpaC. | Q54576324 | ||
Disease-dependent changes in T-cell populations in patients with shigellosis | Q57940370 | ||
Immunopathological patterns in the rectal mucosa of patients with shigellosis: expression of HLA-DR antigens and T-lymphocyte subsets | Q58823351 | ||
Immunity in Shigellosis. II. Protection Induced by Oral Live Vaccine or Primary Infection | Q69156182 | ||
In vivo imaging of quantum dots encapsulated in phospholipid micelles | Q78594973 | ||
Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation | Q79213173 | ||
High immunogenicity of delayed third dose of hepatitis B vaccine in travellers | Q79790829 | ||
Safety and immunogenicity of CVD 1208S, a live, oral DeltaguaBA Deltasen Deltaset Shigella flexneri 2a vaccine grown on animal-free media | Q81445405 | ||
Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major | Q29619125 | ||
T-cell quality in memory and protection: implications for vaccine design | Q30014840 | ||
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. | Q30353189 | ||
Critical role for tumor necrosis factor alpha in controlling the number of lumenal pathogenic bacteria and immunopathology in infectious colitis | Q33552079 | ||
Shigella flexneri 2a strain CVD 1207, with specific deletions in virG, sen, set, and guaBA, is highly attenuated in humans | Q34003433 | ||
Gut-Homing Conventional Plasmablasts and CD27(-) Plasmablasts Elicited after a Short Time of Exposure to an Oral Live-Attenuated Shigella Vaccine Candidate in Humans | Q34068059 | ||
Initial steps of Shigella infection depend on the cholesterol/sphingolipid raft-mediated CD44-IpaB interaction | Q34091098 | ||
Phase I evaluation of delta virG Shigella sonnei live, attenuated, oral vaccine strain WRSS1 in healthy adults | Q34120926 | ||
Ex Vivo kinetics of early and long-term multifunctional human leukocyte antigen E-specific CD8+ cells in volunteers immunized with the Ty21a typhoid vaccine. | Q34150391 | ||
Shigella enterotoxin 1: an enterotoxin of Shigella flexneri 2a active in rabbit small intestine in vivo and in vitro | Q34224319 | ||
Heterogeneity of multifunctional IL-17A producing S. Typhi-specific CD8+ T cells in volunteers following Ty21a typhoid immunization | Q34297117 | ||
Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study | Q34345075 | ||
Epstein-barr virus-induced changes in B-lymphocyte gene expression | Q34347958 | ||
Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine | Q34362872 | ||
IFNγ inhibits the cytosolic replication of Shigella flexneri via the cytoplasmic RNA sensor RIG-I. | Q34388456 | ||
Local entrapment of interferon gamma in the recovery from Shigella dysenteriae type 1 infection. | Q34409399 | ||
Expansion of pathogen-specific mono- and multifunctional Th1 and Th17 cells in multi-focal tuberculous lymphadenitis | Q34603041 | ||
Persistence of local cytokine production in shigellosis in acute and convalescent stages. | Q35380946 | ||
Activation of Salmonella Typhi-specific regulatory T cells in typhoid disease in a wild-type S. Typhi challenge model | Q35637207 | ||
Oral Wild-Type Salmonella Typhi Challenge Induces Activation of Circulating Monocytes and Dendritic Cells in Individuals Who Develop Typhoid Disease | Q35660952 | ||
Shigellosis: innate mechanisms of inflammatory destruction of the intestinal epithelium, adaptive immune response, and vaccine development | Q35696566 | ||
Broadly protective Shigella vaccine based on type III secretion apparatus proteins | Q35805439 | ||
Oral Challenge with Wild-Type Salmonella Typhi Induces Distinct Changes in B Cell Subsets in Individuals Who Develop Typhoid Disease | Q36051755 | ||
Salmonella Typhi-specific multifunctional CD8+ T cells play a dominant role in protection from typhoid fever in humans | Q36634226 | ||
Shigella's ways of manipulating the host intestinal innate and adaptive immune system: a tool box for survival? | Q36703588 | ||
Shigella antigen-specific B memory cells are associated with decreased disease severity in subjects challenged with wild-type Shigella flexneri 2a. | Q36920244 | ||
Antigen-specific B memory cell responses to lipopolysaccharide (LPS) and invasion plasmid antigen (Ipa) B elicited in volunteers vaccinated with live-attenuated Shigella flexneri 2a vaccine candidates | Q37120727 | ||
Inflammatory mediator ultra-low-molecular-weight hyaluronan triggers necrosis of B-precursor leukemia cells with high surface CD44 expression. | Q38676263 | ||
Deletion in the Shigella enterotoxin genes further attenuates Shigella flexneri 2a bearing guanine auxotrophy in a phase 1 trial of CVD 1204 and CVD 1208. | Q39146446 | ||
CD4 CTL, a Cytotoxic Subset of CD4+ T Cells, Their Differentiation and Function. | Q39172071 | ||
Epidemiologic patterns of acute diarrhea and endemic Shigella infections in children in a poor periurban setting in Santiago, Chile | Q39252440 | ||
Induction of necrosis in human neutrophils by Shigella flexneri requires type III secretion, IpaB and IpaC invasins, and actin polymerization | Q39514537 | ||
An essential role for gamma interferon in innate resistance to Shigella flexneri infection. | Q39570534 | ||
P433 | issue | 1 | |
P921 | main subject | Shigella flexneri | Q1644417 |
attenuated vaccine | Q1810913 | ||
P304 | page(s) | 61 | |
P577 | publication date | 2018-03-13 | |
P1433 | published in | Journal of Translational Medicine | Q15716664 |
P1476 | title | T cell mediated immunity induced by the live-attenuated Shigella flexneri 2a vaccine candidate CVD 1208S in humans. | |
P478 | volume | 16 |
Q57929967 | A Novel Proteome Microarray Discriminates Targets of Human Antibody Reactivity following Oral Vaccination and Experimental Challenge |
Q57924523 | Characterization of a serologically atypical Shigella flexneri Z isolated from diarrheal patients in Bangladesh and a proposed serological scheme for Shigella flexneri |
Q92968346 | Role of antigen specific T and B cells in systemic and mucosal immune responses in ETEC and Shigella infections, and their potential to serve as correlates of protection in vaccine development |
Q64244181 | Screening for coeliac disease in children and adults living in a slum of Dhaka, Bangladesh |
Search more.